Skip to content
  • BiotechReality JobFinder
  • Market Analysis
  • Publish on BiotechReality
  • linkedin
  • facebook
  • instagram
  • twitter
BiotechReality Home
BiotechReality – Information Intelligence System for Biopharma
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
Popular
#FDA #Eli Lilly and Company #Johnson&Johnson #FDA Approval #Clinical Data #Cancer #Quarterly Results #Novo Nordisk

Tag: Glucose-Ketone Sensor

Technology Diabetes Healthcare & Pharmaceuticals News

Abbott Libre Duo 10 Day Wins FDA Authorization as World’s First Dual Glucose-Ketone Sensor

  • By Regulatory Intelligence Desk
  • 26 August 2026
Abbott News

Abbott Libre Duo 10 Day has received FDA authorization as the world’s first dual glucose-ketone biowearable, designed to alert people with diabetes to rising DKA risk while tracking glucose in real time.

Tagged Abbott, Abbott Libre, FDA, Glucose-Ketone Sensor
Advertisement

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Autoimmune Diseases
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biologics
  • Biosimilars
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • CDMO
  • Cell Biology
  • Clinical Data
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • CRDMO
  • CRO
  • Cybersecurity
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Legal and Patent Affairs
  • Life Sciences
  • Machine Learning
  • Manufacturing
  • Medical Devices
  • Mental Health
  • Merger & Acquisitions
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Rare Diseases
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs

Discover More

Abbott Libre Duo 10 Day Wins FDA Authorization as World’s First Dual Glucose-Ketone Sensor
Technology Diabetes Healthcare & Pharmaceuticals News

Abbott Libre Duo 10 Day Wins FDA Authorization as World’s First Dual Glucose-Ketone Sensor

26 August 202626 August 2026
Regulatory Intelligence Desk
Johnson & Johnson’s IMAAVY Nipocalimab-aahu Wins FDA Approval as First-Ever Treatment for Warm Autoimmune Hemolytic Anemia
Healthcare & Pharmaceuticals Autoimmune Diseases News Regulatory Approval

Johnson & Johnson’s IMAAVY Nipocalimab-aahu Wins FDA Approval as First-Ever Treatment for Warm Autoimmune Hemolytic Anemia

25 August 202625 August 2026
Regulatory Intelligence Desk
IQVIA Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year
Technology Healthcare & Pharmaceuticals News

IQVIA Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year

22 August 202623 August 2026
BiotechReality Business Intelligence Desk
Moderna With MSD Announces Intismeran KEYTRUDA Melanoma Trial Hits Phase 3 Endpoints
Clinical Trials Clinical Data Healthcare & Pharmaceuticals News

Moderna With MSD Announces Intismeran KEYTRUDA Melanoma Trial Hits Phase 3 Endpoints

21 August 202622 August 2026
Clinical Trials & Data Desk
Genentech Hillsboro Manufacturing Expansion: Roche Subsidiary to Invest $750 Million in New Oregon Device-Fill Facility
Business Healthcare & Pharmaceuticals Manufacturing News

Genentech Hillsboro Manufacturing Expansion: Roche Subsidiary to Invest $750 Million in New Oregon Device-Fill Facility

20 August 202621 August 2026
BiotechReality Business Intelligence Desk
BioMarin Alesta Therapeutics Acquisition: BioMarin Acquires Alesta to Secure Oral HPP Candidate ALE1 for $275M Upfront
Merger & Acquisitions Business Healthcare & Pharmaceuticals News

BioMarin Alesta Therapeutics Acquisition: BioMarin Acquires Alesta to Secure Oral HPP Candidate ALE1 for $275M Upfront

19 August 202619 August 2026
BiotechReality Business Intelligence Desk
Advertisement
BiotechReality JobFinder

  • Product Marketing Data Analyst – Pall (Danaher)
    23 August 2026
  • Financial Analyst, FP&A – Cytiva
    16 August 2026
  • Field Service Account Manager – Bausch+Ströbel
    15 August 2026
  • Process Technician – Roche
    12 August 2026
  • Unified Experience Agentic Platform Product Manager – Eli Lilly and Company
    8 August 2026

BiotechReality Shots Weekly Newsletter

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2026
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
  • linkedin
  • facebook
  • instagram
  • twitter